National Drug Source (NDS) has supported compliant access to U.S. medicines since 2002, addressing critical access gaps when products are not commercially registered locally. We work with healthcare providers to support needs such as:


• Unmet medical need (not registered locally)


• Physician-requested or clinically specific therapies


• Drug shortages or supply disruptions


• Named-patient or compassionate use cases


• Therapeutic gaps and specialty formulations


• Time-critical and emergency treatments


• Innovative or emerging therapies not yet marketed locally

NDS is committed to making high-quality U.S. FDA-approved medicines available to diverse global markets, helping healthcare providers maintain continuity of care and meet patient needs.

We remove operational and regulatory friction by aligning legitimate U.S. sourcing, documentation readiness, and controlled logistics.
Our approach includes:


• Manufacturers regulated by the U.S. FDA


• Clear product origin and batch-level traceability


• Online product and pricing portal


• Structured support for repeat orders

Our systems and processes are designed to meet the expectations of stringent regulatory authorities, enabling smooth import clearance and a transparent, compliant supply chain. This includes serialized inventory control, regulatory and documentation alignment, GDP-compliant handling, controlled logistics, and digital tools that improve visibility and simplify procurement.